Trial
NCT02382523
Acthar on Proteinuria in IgA Nephropathy Patients
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Baylor College of Medicine
Collaborators
—
Condition
IgA Nephropathy
Intervention
Acthar 80 unit injection
Why stopped
There were no subjects enrolled locally on this study since it opened. Local IRB closure has been requested.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-05